Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 101,003

Document Document Title
WO/2018/004010A1
In order to provide a device for thawing preserved vitrified germ cells and a thawing method that simultaneously realize a high conception rate and facilitate transplantation work, the device for thawing (1) is equipped with a mounting d...  
WO/2018/002581A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i) heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii) heating the biomass t...  
WO/2018/002520A1
Use of a selenised compound for increasing the ethanol content of a composition, said process comprising at least one step for the alcoholic fermentation of said composition carried out in the presence of said selenised compound in a con...  
WO/2018/002248A1
The present invention relates to the field of preservation of microorganisms, and in particular provides a 2-compartment system comprising a first compartment comprising microcapsules with microorganisms in a non-aqueous composition in t...  
WO/2018/004586A1
The present invention discloses the use of probiotics for therapeutic management of major depressive disorder (MDD). Specifically, the invention discloses the method of therapeutically managing MDD in mammals with Irritable bowel syndrom...  
WO/2018/000043A1
The present invention relates to a cell coated with a layer of crystalline Metal Organic Framework (MOF).  
WO/2018/003641A1
Provided is an improvement in C4 dicarboxylic acid productivity in a host cell. A polypeptide that comprises the amino acid sequence represented by SEQ ID NO:2 or an amino acid sequence having 90% or more sequence identity to the aforesa...  
WO/2018/005604A1
The present invention provides a method for inhibiting the growth of food-borne pathogens, nosocomial pathogens and spoilage microorganisms, the method comprising the steps of: contacting at least one lactic acid bacterium strain selecte...  
WO/2018/005655A2
The present disclosure describes methods for generating microbial strains expressing a heterologous bacterial hemoglobin gene that produce biomolecules of interest. In aspects, the disclosure provides novel bacterial strains, which expre...  
WO/2018/002579A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i)heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii)heating the biomass to ...  
WO/2018/002331A1
Provided herein is a composition comprising: a) about 25% up to about 75% of a plasmolysed micro-organism by weight of the total weight of the composition; b) about at least greater than 20% up to about 60% by weight flavor or fragrance,...  
WO/2018/005599A3
The present invention provides a method for inhibiting the growth of pathogens in an animal feed comprising the steps of: contacting an animal feed with at least one lactic acid bacterium strain selected from the group consisting of Lact...  
WO/2017/223501A1
Methods for spray drying gram negative bacteria are provided. Such spray drying methods are performed under conditions that allow for the spray dried composition to retain the biological activity of interest of the gram-negative bacteria...  
WO/2017/223273A1
In certain aspects, described herein are methods, bacteria, and compositions for the reduction of the amount, activity and/or proliferation of colonic group 3 innate lymphoid cells (ILC3s) and for the treatment and/or prevention of disea...  
WO/2017/222142A1
The present invention provides Bacillus licheniformis strain NY1505 (accession number KCTC13021BP) for a high yield of an α-glucosidase inhibitor. Bacillus licheniformis strain NY1505, according to the present invention, is a novel stra...  
WO/2017/223364A1
The inventions disclosed herein relate to the findings that Lactobacillus reuteri (L. reuteri) bacteria isolated from dog saliva is capable of modulating a subject's body weight. In certain aspects, the inventions disclosed herein relate...  
WO/2017/221873A1
The present invention provides a mutant coleoptera luciferase, which has a mutation of, in the amino acid sequence of wild type North America firefly luciferase among amino acid sequences encoding wild type coleoptera luciferases, substi...  
WO/2017/219455A1
The present invention provides a gene for encoding a truncated human keratinocyte growth factor. The gene is one of the following nucleotide sequences: 1) the sequence with SEQ ID No:1 in a sequence list; and 2) a DNA sequence that has a...  
WO/2017/223569A1
The present invention provides for a composition comprising: (a) a first host cell capable of producing L-DOPA; and (b) a modified host cell is capable of converting L-DOPA into hydroxytyrosol (HTy); wherein any one or both of the first ...  
WO/2017/223538A1
Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engin...  
WO/2017/221559A1
The invention is intended to metabolize acetic acid in a medium at the time of culture, such as ethanol fermentation by yeast, and to reduce acetic acid concentration. Specifically, the invention relates to a recombinant yeast resultin...  
WO/2017/221591A1
Provided are a cell processing system and a cell supply method whereby a cell in a desired state can be provided at an appropriate time. A cell processing system (10) is provided with a plurality of culture units (15). Each of the cultur...  
WO/2017/221765A1
A microorganism that has 16S rRNA gene containing any of nucleic acids (a)-(c) and is capable of degrading a lignocellulose-based biomass: (a) a nucleic acid having a base sequence represented by SEQ ID NO: 1 or 2; (b) a nucleic acid hav...  
WO/2017/222141A1
The present invention provides a Bacillus subtilis strain (accession number KCTC13020BP) enabling a high yield of thrombolytic enzymes. A Bacillus subtilis strain GDN, according to the present invention, shows notably high thrombolytic e...  
WO/2017/222034A1
The present invention is a modified fibroin including a domain sequence represented by formula 1: [(A)n motif-REP]m, wherein, compared to a fibroin derived from nature, the domain sequence contains an amino-acid sequence that locally inc...  
WO/2017/221905A1
[Problem] To provide a β-glucan-producing fungus without a melanin pigment formation ability or with a low melanin pigment formation ability, which is mutated from a common β-glucan-producing fungus, does not have a melanin pigment for...  
WO/2017/219159A1
The invention relates to an algae filter and bioreactor for individual use, characterised in that it comprises a container (7) of culture medium and a mini water pump (10) that recirculates the culture medium, the medium being pumped thr...  
WO/2017/223025A1
The invention provides genetically engineered microorganisms useful for the production of butyrate. The bacterium of the invention comprises inactivation/deletion of genes encoding lactate dehydrogenase (ldhA) and alcohol dehydrogenase (...  
WO/2017/219987A1
Provided is a Schizochytrium limacinum mutant strain. The Schizochytrium limacinum mutant strain was deposited in the China Centre for Type Culture Collection (CCTCC) with a deposit number of CCTCC NO: M2012494 on 03 December 2012, and t...  
WO/2017/217460A1
A fusion protein containing at least two proteins, said fusion protein being characterized in that the at least two proteins are fused to each other through a peptide linker having the following amino acid sequence: Xm(PYn)qPZr. In the a...  
WO/2017/217753A1
The present invention relates to a strain of the genus Agathobaculum having an effect of preventing or treating degenerative brain diseases, and a use thereof. Since the intestinal microorganism strain of Agathobaculum butyriciproducens ...  
WO/2017/216610A1
The present invention relates to a bacterial strain isolated from the species Leptospirillum sp., Likallfu, deposited in the CChRGM (Colección Chilena de Recursos Genéticos Microbianos, Chillán, Chile) on 17 October 2015 with referenc...  
WO/2017/218680A1
Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.  
WO/2017/217350A1
The purpose of the present invention is to provide an antimicrobial and antiviral drug that contains a naturally derived component as an active component and is efficacious against various kinds of microorganisms including fungi and viru...  
WO/2017/217794A1
Provided is technology for conferring enhanced tolerance and/or enhancing tolerance to herbicide of a plant and/or algae using amino acid variants of protoporphyrinogen oxidase derived from prokaryotes.  
WO/2017/217532A1
A lactobacillus fermentation promoter and fermentation method are provided that are suitable to use in food production. The invention relates to a lactobacillus fermentation promoter that contains a compound having a purine skeleton with...  
WO/2017/216136A1
The present invention describes a recombinant yeast cell functionally expressing one or more heterologous nucleic acid sequences encoding for ribulose-1,5-phosphate carboxylase/oxygenase (EC4.1.1.39; Rubisco), and optionally one or more ...  
WO/2017/217533A1
A lactobacillus fermentation promoter is provided which is suitable for use in food production. The invention relates to a streptococcus thermophilus fermentation promoter, and a production method thereof, which contains a solution prepa...  
WO/2017/219004A2
Some aspects of this disclosure provide engineered exopolysaccharide-associated proteins, engineered bacteria expressing such proteins, and engineered biofilms comprising such proteins. Some aspects of this disclosure provide methods for...  
WO/2017/217793A1
Provided is technology for conferring enhanced herbicide tolerance and/or enhancing herbicide tolerance of plants and/or algae using a protoporphyrinogen oxidase derived from prokaryotes or its amino acid variants.  
WO/2017/214673A1
The present invention relates generally to a novel yeast strain deposited with the National Measurement Institute and assigned Accession No. V16/014811, and cultures thereof. The present disclosure also relates generally to the use of ye...  
WO/2017/215174A1
Provided are a marine bacterial gene LfliZ and a use thereof. A nucleotide sequence of the marine bacterial gene LfliZ is shown as SEQ ID NO.1. Also provided are a recombinant protein LfliZ expressed by the gene LfliZ and a use of the ma...  
WO/2017/217514A1
The purpose of the present invention is to provide: a liver-type fatty acid-binding protein preparation by which, in a measurement using a specifically binding substance, the range of variation of a measured value caused by a liver-type ...  
WO/2017/217116A1
In the production of ethyl alcohol by taking advantage of autofermentation of a microalga, a step for concentrating or recovering alga cells by centrifugation, filtration, etc. is omitted or simplified so as to save labor and facility re...  
WO/2017/214919A1
Provided are mycobacterium genetically-engineered bacteria and applications thereof in the preparation of a steroidal compound. The mycobacterium genetically-engineered bacteria are mycobacteria lacking of all of acyl-CoA dehydrogenase f...  
WO/2017/216818A1
Method of culture of an anaerobic bacterium, obligate or facultative, in particular Lactobacillus sp., which comprises the inoculation of the anaerobic bacteria in an extract, homogenized or entire, of the unicellular microalgae in a sol...  
WO/2017/214690A1
The present invention relates to methods for deactivating micro-organisms that are detrimental to the beer brewing fermentation process as a function of the impact of pH and temperature, or of the chlorine dioxide concentration and tempe...  
WO/2017/215204A1
Provided in the present invention are a bacillus subtilis recombinant strain and a preparation method therefor and an application thereof. The recombinant strain is obtained by knocking out or inactivating ten protease genes from Bacillu...  
WO/2017/217453A1
Provided is a cellulase having high binding ability to cellulose substrates. Cellulase having a xylanase carbohydrate binding module (CBM).  
WO/2017/218380A1
Systems and methods that include starch derived from grain as a carbon source for propagation of microorganisms.  

Matches 351 - 400 out of 101,003